Posts

Cambridge, Massachusetts’ Kendall Square just got a little more crowded. Following announcements of new facilities made by Takeda, Sanofi and life sciences giant Bayer which opened its new research and innovation center in the busy biotech hotspot known as Genetown.

Bayer is building an oncology powerhouse. The Germany-based biopharma leader is on a mission to become one of the top 10 oncology companies by 2030, and an ambitious mission requires an equally driven leadership team. To that end, Bayer snagged ex-GSK global oncology head Christine Roth to lead the company’s Oncology Strategic Business Unit, then dipped into GSK waters again to bring Tara Frenkl on board as head of oncology development.